论文部分内容阅读
目的分析对非ST段抬高心肌梗死患者进行血清cTnⅠ联合Hcy水平检测的临床诊断意义。方法将2015年4月~2016年4月本院收治的120例非ST段抬高心肌梗死患者分为观察组,将同期在本院进行体检的120例健康人员分为对照组,利用光化学免疫法对两组观察对象的血清cTnⅠ水平进行检测,利用全自动生化分析仪对患者的Hcy水平进行检测。对比观察两组患者血清cTnⅠ联合Hcy水平的差异,分析血清cTnⅠ联合Hcy水平对非ST段抬高心肌梗死的临床诊断意义。结果观察组患者的血清cTnⅠ联合Hcy水平明显高于对照组;观察组cTnⅠ阳性率、Hcy阳性率、cTnⅠ+Hcy阳性率均高于对照组,各组数据差异有统计学意义(P<0.05)。结论血清cTnⅠ、Hcy阳性提示患者有非ST段抬高心肌梗死的风险,对患者进行血清cTnⅠ联合Hcy水平检测可以判定治疗效果,对非ST段抬高心肌梗死的诊治具有较高的临床诊断价值。
Objective To analyze the clinical significance of serum cTnI and Hcy levels in patients with non-ST elevation myocardial infarction. Methods From April 2015 to April 2016, 120 patients with non-ST-segment elevation myocardial infarction admitted to our hospital were divided into observation group and 120 healthy subjects who were in our hospital during the same period were divided into control group, France two groups of subjects were detected serum cTn Ⅰ levels were detected by automatic biochemical analyzer in patients with Hcy levels were detected. To compare the differences of serum cTnI and Hcy between the two groups, and to analyze the clinical significance of serum cTnI and Hcy levels in non-ST segment elevation myocardial infarction. Results The serum levels of cTnI and Hcy in the observation group were significantly higher than those in the control group. The positive rate of cTnⅠ, the positive rate of Hcy and the positive rate of cTnⅠ + Hcy in the observation group were significantly higher than those in the control group (P <0.05) . Conclusions The positive serum levels of cTnⅠ and Hcy suggest that patients with non-ST-segment elevation myocardial infarction risk. The serum cTnⅠ and Hcy levels can be used to determine the therapeutic effect in patients with non-ST-segment elevation myocardial infarction, which has a high clinical diagnostic value .